229.02 - 234.51
169.21 - 260.10
55.82M / 54.92M (Avg.)
32.24 | 7.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
19.01%
Revenue growth under 50% of VUZI's 68.48%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
20.20%
Positive gross profit growth while VUZI is negative. John Neff would see a clear operational edge over the competitor.
31.66%
Positive EBIT growth while VUZI is negative. John Neff might see a substantial edge in operational management.
31.66%
Positive operating income growth while VUZI is negative. John Neff might view this as a competitive edge in operations.
36.26%
Positive net income growth while VUZI is negative. John Neff might see a big relative performance advantage.
38.18%
Positive EPS growth while VUZI is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
38.18%
Positive diluted EPS growth while VUZI is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-1.75%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-1.76%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-2.43%
Dividend reduction while VUZI stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
71.11%
OCF growth above 1.5x VUZI's 32.42%. David Dodd would confirm a clear edge in underlying cash generation.
77.80%
FCF growth above 1.5x VUZI's 27.22%. David Dodd would verify if the firm’s strategic investments yield superior returns.
808.24%
Positive 10Y revenue/share CAGR while VUZI is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
100.88%
5Y revenue/share CAGR above 1.5x VUZI's 1.26%. David Dodd would look for consistent product or market expansions fueling outperformance.
63.35%
3Y revenue/share CAGR at 50-75% of VUZI's 99.30%. Martin Whitman would question if the firm lags behind competitor innovations.
796.14%
10Y OCF/share CAGR above 1.5x VUZI's 65.73%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
98.55%
Positive OCF/share growth while VUZI is negative. John Neff might see a comparative advantage in operational cash viability.
47.55%
3Y OCF/share CAGR 1.25-1.5x VUZI's 37.50%. Bruce Berkowitz might see if strategic cost controls or product mix drove recent gains.
1050.61%
Positive 10Y CAGR while VUZI is negative. John Neff might see a substantial advantage in bottom-line trajectory.
113.58%
5Y net income/share CAGR above 1.5x VUZI's 33.47%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
81.45%
3Y net income/share CAGR above 1.5x VUZI's 4.24%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
300.33%
Below 50% of VUZI's 934.49%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
7.19%
Below 50% of VUZI's 173.85%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
-15.68%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
62.49%
Dividend/share CAGR of 62.49% while VUZI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
34.47%
3Y dividend/share CAGR of 34.47% while VUZI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
73.02%
AR growth well above VUZI's 45.95%. Michael Burry fears inflated revenue or higher default risk in the near future.
22.38%
We show growth while VUZI is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
5.05%
Positive asset growth while VUZI is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-4.52%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-0.34%
We’re deleveraging while VUZI stands at 270.50%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-3.45%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
3.43%
SG&A declining or stable vs. VUZI's 9.69%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.
